Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Endoscopic treatment of bleeding peptic gastroduodenal ulcer

Endoscopic practice regarding dosage or administration varies even in areas with established evidence, shows the latest issue of the Scandanavian Journal of Gastroenterology.

News image

fiogf49gjkf04

Dr Sven Adamson and colleagues from Denmark investigated treatment practice in non-variceal upper gastrointestinal bleeding caused by gastroduodenal ulcer.

The researchers assessed how it adheres to the best evidence as documented in randomized studies and meta-analyses.

92% of departments attempted endoscopy before surgery
Scandinavian Journal of Gastroenterology

The team surveyed the literature to identify appropriate practices.

The researchers developed a structured multiple choice questionnaire.

The team mailed the questionnaires to all departments treating upper gastrointestinal bleeding.

The researchers reported that all 42 departments responded.

All departments had therapeutic gastroscopes and equipment necessary for endoscopic hemostasis, and 90% had written guidelines.

The team noted that adjuvant pharmacologic treatment included tranexamic acid in 38%.

The researchers found that proton-pump inhibitors were used by all departments, with 29% starting prior to endoscopic treatment.

The team observed that 19% of departments used continuous proton-pump inhibitor infusion, 3 of them starting with a bolus dose.

In 50% of departments, an anesthesiologist was always present regardless of whether endotracheal intubation was used or not.

The team found that 10% of departments did not treat Forrest IIa and IIb ulcers, while IIc ulcers were treated by 36%.

In 10% of departments, clots were never removed.

The researchers found that in 2 departments attempts were made to remove resistant clots by mechanic means.

The researchers found that 17% of departments used monotherapy with epinephrine.

The team observed that 59% of departments always used dual therapy, and 19% injected less than 10 ml.

In rebleeding, 92% of the departments attempted endoscopic treatment before surgery, and used epinephrine in 79% of cases.

The team noted that the remainder of departments used epinephrine or polidocanol at the discretion of the endoscopist.

The team found that 2 out of 3 departments used high-dependency or intensive-care units for surveillance.

In addition, the researchers observed that 17% of departments applied scheduled second-look gastroscopy.

Dr Adamson's team concluded, “Practice is variable, even in areas with established evidence based on randomized controlled studies, such as dosage and way of administration and duration of proton-pump inhibitor treatment.”

“Injection treatment used as monotherapy and the volume used, including ulcers with clots for treatment, and the use of scheduled second-look endoscopy.”

“Since the rebleeding rate has remained unchanged for decades, and rebleeding implies increased surgery and mortality rates, appropriate practices must be promoted in order to improve results.”

“Development and implementation of national guidelines may facilitate the process.”

Scand J Gastroenterol 2007: 42(3): 318-23
06 March 2007

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us